Research on blood flow in the brain, from the lab of Chris Schaffer and Nozomi Nishimura, could help inform better therapies for people with dementia, including Alzheimer's disease.
A newly discovered type of genetic mutation in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the New York Genome Center.
A naturally produced chemical exacerbates infection by a common bacteria, rendering the infection significantly harder for the body to clear, according to new Cornell cross-campus research.
Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group to assist in the development of an international hospital in Shanghai, China.
Creating new opportunities for industry partnerships and increasing engagement with the world beyond the lab could help researchers make a broader impact and meet grand challenges, said speakers at the “Deep Tech Eats Social Media for Lunch” panel, held Jan. 28 in the Upson Hall lounge.
Dr. Lewis C. Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded the 2016 Wolf Prize in Medicine for his research discoveries.
Researchers from Weill Cornell Medicine and the U.S. government have created a checklist to identify patients who develop a common and potentially fatal secondary meningitis infection.
The South Side of Chicago, where Dejah Powell ’18 grew up, is known as an urban food desert. Powell, an environmental and sustainability science major, is helping to change that.